• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Alimera Sciences Inc

+ Add to Watchlist

ASZ:GR

4.369 EUR 0.029 0.67%

As of 13:34:26 ET on 07/29/2014.

Snapshot for Alimera Sciences Inc (ASZ)

Open: 4.386 Day's Range: 4.369 - 4.429 Volume: 100
Previous Close: 4.340 52wk Range: 1.273 - 6.050 1-Yr Rtn: +22.31%

Stock Chart for ASZ

No chart data available.
  • ASZ:GR 4.369
  • 1D
  • 1M
  • 1Y
4.340
Interactive ASZ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ASZ

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.2600
Est. PEG Ratio -
Market Cap (M EUR) 176.18
Shares Outstanding (M) 40.33
30 Day Average Volume 34
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ASZ

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ASZ

Alimera Sciences Inc. is a biopharmaceutical company. The Company researches, develops and commercializes prescription ophthalmic pharmaceuticals. Alimera Sciences is focused on diseases affecting the lining in the back of the eye, or retina.

C Daniel Myers "Dan"President/CEO/Co-FounderRichard S Eiswirth Jr "Rick"CFO/COO/Secretary
Kenneth Green "Ken"Senior VP/Chief Scientific OfcrDavid Holland "Dave"Senior VP:Sales & Marketing
More Company Profile & Key Executives for ASZ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil